U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 3, Informative) by stretch611 on Wednesday January 23 2019, @05:20PM (1 child)
Type I Diabetes has no relationship whatsoever to diet and exercise. While you are attempting to blame big business, they are not the problem in this case. In fact heredity has a lot to do with this.
Type 2 Diabetes can be related to diet and exercise, but even that is not the full story as that also has a lot to do with heredity. Not to mention, but most Type 2 diabetics do not require insulin. (At least not initially.) However, the drug prices for type 2 diabetes can make insulin look cheap. (And if the diabetes progresses, type 2 diabetics will require insulin.)
Now with 5 covid vaccine shots/boosters altering my DNA :P
(Score: 0) by Anonymous Coward on Wednesday January 23 2019, @06:51PM
We know the cure for type 1 diabetes, people just find it distasteful.